Crossmark

Preregistered multi-site preclinical randomized controlled trials: the beginning of a new day in reverse translational science?

Published Online: 2025-03-20

Published Print: 2025-05

Authors

Leggio, Lorenzo https://orcid.org/0000-0001-7284-8754
Colombo, Giancarlo
Funding

Funding for this research was provided by:

U.S. Department of Health & Human Services | National Institutes of Health
License Information

Text and Data Mining valid from 2025-03-20

Version of Record valid from 2025-03-20
More Information

Article History

Received: 6 March 2025

Accepted: 10 March 2025

First Online: 20 March 2025

Competing interests

: The authors declare no competing interests.

Document is current